“Brentuximab Vedotin Effects on Prognosis of Refractory and Relapsed Peripheral T-Cell Lymphoma: A Systematic Review”. 2019. Revista De Medicina E Saúde De Brasília 7 (2). https://portalrevistas.ucb.br/index.php/rmsbr/article/view/9251.